Skip to main content
Signal8

Schwartz Elissa J.

SEC insider (Form 3/4/5 filer). CIK 0001827177. Director at GALECTIN THERAPEUTICS INC (GALT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 16, 2026. Located in NORCROSS, GA.

Companies Schwartz Elissa J. has filed insider reports for

  • GALECTIN THERAPEUTICS INC (GALT): Director
Schwartz Elissa J. profile photo

Schwartz Elissa J.

CIK: 0001827177

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALECTIN THERAPEUTICS INC logo
GALT

GALECTIN THERAPEUTICS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • GALECTIN THERAPEUTICS INC logo
    GALT

    GALECTIN THERAPEUTICS INC

    Jan 16, 2026
    Award

    Stock option (right to buy)

    Direct
    60K shares-
  • GALECTIN THERAPEUTICS INC logo
    GALT

    GALECTIN THERAPEUTICS INC

    Jan 23, 2025
    Award

    Stock Option (right to buy)

    Direct
    60K shares-

1-2 of 2